Feasibility of high-intensity training in asthma by Tønnesen, Louise Lindhardt et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Feasibility of high-intensity training in asthma
Tønnesen, Louise Lindhardt; Sørensen, E D; Hostrup, Morten; Porsbjerg, Celeste; Bangsbo,
Jens; Backer, Vibeke
Published in:
European Clinical Respiratory Journal
DOI:
10.1080/20018525.2018.1468714
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Tønnesen, L. L., Sørensen, E. D., Hostrup, M., Porsbjerg, C., Bangsbo, J., & Backer, V. (2018). Feasibility of
high-intensity training in asthma. European Clinical Respiratory Journal, 5(1), [1468714].
https://doi.org/10.1080/20018525.2018.1468714
Download date: 03. Feb. 2020
Feasibility of high-intensity training in asthma
L. L. Toennesen a, E. D. Soerensena, M. Hostrupa,b,c, C. Porsbjerga, J. Bangsbob and V. Backer a,c
aDepartment of Respiratory Medicine, Respiratory Research Unit, Bispebjerg Hospital, Copenhagen, Denmark; bSection of Integrative
Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark; cIOC Research Center
Copenhagen, Center for Injury Prevention and Protection of Athlete Health, Copenhagen, Denmark
ABSTRACT
Background: High-intensity interval training is an effective and popular training regime but its
feasibility in untrained adults with asthma is insufficiently described.
Objective: The randomized controlled trial ‘EFFORT Asthma’ explored the effects of behavioural
interventions including high-intensity interval training on clinical outcomes in nonobese seden-
tary adults with asthma. In this article we present a sub analysis of data aiming to evaluate if
patients’ pre-intervention levels of asthma control, FEV1, airway inflammation and airway hyper-
responsiveness (AHR) predicted their training response to the high-intensity interval training
program, measured as increase in maximal oxygen consumption (VO2max).
Design: We used data from the EFFORT Asthma Study. Of the 36 patients randomized to the 8-
week exercise intervention consisting of high-intensity training three times per week, 29 patients
(45% females) completed the study and were included in this data analysis. Pre-intervention
assessment included the asthma control questionnaire (ACQ), spirometry, fractional exhaled nitric
oxide (FeNO) and AHR to mannitol. VO2 max was measured during an incremental cycle test.
Results: The majority of included patients had partly or uncontrolled asthma reflected by a mean
(SD) ACQ at 1.7 (0.6). Median (IQR) FeNO was 28.5 (23.8) ppb and 75% had a positive mannitol
test indicating AHR.
The association between patients’ training response measured as increase in VO2max and pre-
intervention ACQ scores was not statistically significant (p = 0.49). Likewise, the association
between patients’ increase in VO2max and FeNO as well as AHR was not statistically significant
(p = 0.80 and p = 0.58).
Conclusions: Included asthma patients could adhere to the high-intensity interval protocol and
improve their VO2max regardless of pre-intervention levels of asthma control, airway inflamma-
tion and AHR.
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Introduction
Engaging in physical activity can be a challenge for
patients with asthma, since many experience exercise-
induced asthma symptoms [1]. This may cause them to
avoid physical activity, leading to deconditioning and
poor cardiorespiratory fitness [2,3].
High-intensity interval training is today being prac-
ticed within a number of rehabilitation programs espe-
cially in programs for patients with cardiovascular
disease [4,5], because of its superior efficacy to improve
cardiorespiratory fitness and endurance performance
when compared to low- to moderate-intensity training
[4,6]. Our current knowledge about the feasibility of
exercise interventions in asthma is limited by the fact
that the majority of training studies have been based on
low- and moderate-intensity training.
We recently performed the EFFORT Asthma
study, an 8-week RCT exploring the effects of beha-
vioural interventions including high-intensity inter-
val training on clinical outcomes in nonobese
sedentary adults with asthma [7]. Here we demon-
strated that high-intensity training was safe and
improved VO2max significantly in the overall group
of patients randomized to follow the 8-week training
program. In the present article, we aim to explore if
patients’ pre-intervention levels of asthma control,
FEV1, airway inflammation and airway hyperrespon-
siveness (AHR) predicted their training response fol-
lowing the high-intensity interval training program,
measured as increase in maximal oxygen consump-
tion (VO2max).
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Methods
The methodology has been described in detail pre-
viously [7].
Design
The study is a sub-analysis of data from the EFFORT
Asthma study [7], (ClinicalTrials.gov NCT02355964).
Given the present study’s focus is an in-depth analysis
of the feasibility of the high-intensity interval training,
the current study only includes data from patients who
were randomized to the exercise group (n = 29).
Each patient gave written informed consent and the
study was approved by the local Ethics Committee of
Copenhagen, Denmark (H-4-2013-116)).
Patients
Patients were recruited consecutively through newspaper
advertisements and through the outpatient asthma clinic
at Bispebjerg Hospital, Copenhagen, Denmark. The
inclusion criteria were as follows: (i) 18–65 years of age,
(ii) a diagnosis of asthma confirmed through an inter-
view with a study physician and a positive diagnostic test
demonstrating variable airflow obstruction: either a posi-
tive mannitol test, methacholine test or reversibility test,
(iii) Asthma control questionnaire score (ACQ score) ≥
1.0, (iv) body mass index (BMI) >20 and <30 kg/m2, (v)
untrained (less than 1 h of physical exercise per week),
and (vi) on a stable treatment regime (either receiving no
asthma controller medicine (i.e. inhaled corticosteroid
(ICS) or ICS combined with long-acting beta-2 agonist
(LABA), or on a stable dose throughout the last 3
months). Patients were excluded if they had been hospi-
talized for asthma within the last 3 months, had a lower
respiratory tract infection within the last 3 months, and if
they had a medical history of other chronic lung disease,
including chronic obstructive pulmonary disease or
other disease that could compromise safety.
Study flow
After patients had signed informed consent, a screen-
ing visit was performed to assess in and exclusion
criteria and confirm the diagnosis of asthma with
spirometry and provocation test(s). An exercise test
was performed on a separate day.
The exercise intervention
The exercise intervention consisted of 8 weeks of high-
intensity interval training using the 10-20-30 training
concept [6]. The training was performed on indoor spin-
ning bikes (TopSpin, Abilica, Denmark) three times per
week and was supervised by a spinning instructor. The
training comprised of a 10-min warmup at a low inten-
sity followed by two to four 5-min intervals. Each 5-min
interval consisted of five consecutive 1-min intervals
divided into 30, 20 and 10 s at an intensity corresponding
to <30%, <60% and >90% of maximal heart rate, respec-
tively. Intervals were separated by 2-min recovery peri-
ods and all sessions included a 10-min cool-down period
consisting of biking at a low intensity. In the first
2 weeks, patients completed two 5-min intervals per
session, three intervals were completed per session dur-
ing the following 3 weeks, and four intervals per session
during the remaining 3 weeks. During every training
session, patients wore a heart rate monitor (Polar h7
heart rate monitor, Polar, Denmark) which enabled
them to follow their own heart rate on a large screen
on the back wall. The target heart rate during each 5-min
interval was 90–100% of maximal heart rate (HRmax).
All heart rate data from each training session was regis-
tered and stored with the POLAR team system software
(Polar, Denmark).
The spinning instructors kept a record of patients’
attendance to the training sessions and a minimum of
21 training sessions during the 8-week intervention
period were required.
Safety
Patients were instructed to take 2 puffs of their regular
short-acting beta-2 agonist (SABA) 10–15 min prior to
the training and during the training sessions if neces-
sary to prevent bronchoconstriction. All training ses-
sions were carried out in a hospital setting. To ensure
patients’ safety during the training session, safety
guidelines were taught to all trainers. They were taught
to call the hospital’s emergency assistance team in the
case of a major serious event which was defined as
follows: 1) if a patient suffered from asthma symptoms
that did not pass after 1–2 puffs of SABA or 2) if a
patient experienced dizziness or discomfort during the
training session that did not pass after a short pause
from training (1–2 min.). Major serious events were
systematically recorded. In contrast, minor events such
as if a patient decided to take 1–2 puffs of extra SABA
during the training session or wanted a 1–2 min break
from the training were not recorded.
Assessment
All tests were performed by trained staff members and
test equipment was calibrated daily according to the
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manufacturers’ instructions. Prior to pulmonary func-
tion tests and provocation tests, patients were asked to
withhold SABA for at least 8 h, LABA for at least 12 h,
ICS for at least 24 h and leukotriene receptor antago-
nists and antihistamines for at least 3 days.
Asthma control
Level of asthma control was assessed with the validated
5-item version of the Juniper ACQ [8,9]. Responses are
given on a 7-point scale and the overall score is the
mean of the responses (0 = totally controlled,
6 = severely uncontrolled). A cut-off point at 1.5 was
used to define uncontrolled asthma [8].
Spirometry
FEV1 and forced vital capacity (FVC) were measured
with a handheld spirometer, EasyOne (ndd
Medizintechnik AG, Zürich, Switzerland) according to
the standards specified by the European Respiratory
Society [10]. Predicted normal values based on sex, height
and age were calculated from the National Health and
Nutrition Examination Survey (NHANES) reference
values [11].
Mannitol provocation test
Patients inhaled an empty capsule followed by capsules
with increasing doses of mannitol (from 5 to 635 mg)
until maximum doses had been reached or a 15%
reduction in FEV1 had occurred. A positive test
response indicating AHR was defined as a 15% fall or
more at a dose ≤ 635 mg. In addition, a response-dose
ratio (RDR) was calculated as the percentage fall in
FEV1 divided by the cumulative dose of inhaled man-
nitol (in mg) [12].
Methacholine provocation test
The methacholine test was performed only in patients
who had a negative mannitol test, in order to verify the
diagnosis of asthma. Tests were carried out on a sepa-
rate day from the Mannitol test. Using an inhalation-
triggered dosimeter (Spira Respiratory Care Centre
Ltd, Hämeenlinna, Finland), subjects inhaled nebulized
isotonic saline for baseline measurement followed by
1–5 incremental doses of nebulized methacholine, as
described by Crapo [13]. Two minutes after each
inhaled dose, a spirometry measurement was carried
out. The test was stopped and considered positive when
FEV1 decreased by 20% or more, or after accumulating
a maximal dose of 8 µmol inhaled methacholine.
Reversibility test
Reversibility testing was performed only if patients
were unable to undergo bronchial provocation tests
(i.e. FEV1%pred < 70%), in order to verify the diag-
nosis of asthma. A significant reversibility was defined
as a 12% increase in FEV1 (and minimum 250 mL)
15 min after 4 puffs of terbutaline [14].
Fraction of exhaled nitric oxide (FeNO) and atopy
FeNO was analysed following the ERS/ATS recommen-
dations [15] and skin prick tests were performed
according to European standards [16].
Exercise testing
Prior to exercise testing, patients refrained from severe
physical activity for at least 24 h. The cardiopulmonary
exercise test was performed in accordance with the
American Thoracic Society’s guidelines [17] on a bike
ergometer (Monark 839E, Stockholm, Sweden). The
test started at an intensity of 50 W and increased by
2 W every 6 s until exhaustion. Oxygen uptake was
simultaneously recorded breath-by-breath with a gas-
analyser system (Master Screen JAEGER CPX, Viasys
Healthcare, Hoechberg, Germany). Before testing, all
patients were instructed to inhale two puffs of their
regular SABA. VO2 max was measured as the highest
oxygen consumption in a period of 30 s divided by the
total body weight. The criteria used to end the bicycle
tests were as follows: Either an elevated respiratory
exchange ratio (RER) ≥1.1, achievement of at least 90
percentage of age-adjusted estimate of maximal heart
rate (HRmax) and/or reaching a VO2 plateau within 2
and 2.2 ml·kg(−1)·min(−1). Peak power output (PPO)
was defined as the highest load (watt) reached during
the exercise test. HRmax was measured during the test.
Statistical analyses
Data was stored and analysed using the statistical soft-
ware SPSS 23 (SPSS Inc. Illinois. USA). For continuous
outcomes, means (standard deviations; SDs) were com-
pared across groups using one-way analysis of variance,
and Kruskal–Wallis one-way analysis of variance was
used when the outcome was not normally distributed.
In order to enable adjustment for potential confounders,
linear regression models were used to assess the effects of
pre-intervention ACQ, FEV1, FeNO and AHR on
improvements in VO2 max and PPO. For categorical
outcomes, proportions were compared across groups
using Chi2-tests. Log-transformed values of RDR to
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mannitol were used in all analyses in order to meet
normal distribution. P ≤ 0.05 was used as a threshold
for declaring statistical significance. Results are presented
as means (SD) unless specified.
Results
A total of 36 patients from the EFFORTAsthma studywere
randomized to the training group, and of these, 29 com-
pleted the study and were included in the present data
analyses. Reasons for drop-out were: a) intercurrent illness
not related to the intervention (n = 3), b) lack of time to
complete the training program (n= 3) and c) not able to get
in contact with the patient for follow-up examina-
tions (n = 1).
Baseline characteristics
Of the 29 included patients, 55%were men, 2 out of 3 were
treated with ICS, mean FEV1was 84 [13] %pred andmean
ACQ scorewas 1.7 (0.6) (Table 1). A total of 28 (97%) had a
mannitol test performed, and of these, 21 (75%) had a
positive test. The remaining 7 patients had a positive
methacholine test, and the patient who could not perform
a mannitol test due to an FEV1%pred <70 had a positive
reversibility test.
Drop-outs
A higher proportion of men dropped-out during the
intervention period than women (27% vs. 7%), albeit
not statistically different (p = 0.21). There were no
significant differences in age, BMI, ACQ score, use
of ICS, FEV1%pred., FVC %pred., FeNO or AHR to
mannitol between those patients who dropped out
and those who completed the study (data not
shown).
Training sessions
Patients completed (mean (95% CI)) 21.9 (20.9;21.9)
training sessions. No major serious events were seen.
Recordings of heart rates (HR) from all attended train-
ing sessions were obtained in 26 patients (90%).
Missing data was due to technical problems with the
pulse sensors. The heart rates (HRs) during the train-
ing sessions relative to HRmax are shown in Figure 1.
The time spent between 90 and 100% of HRmax during
each of the training sessions were 6.3 (2.1) min during
the first 2 weeks, 8.8 (3.6) min during the following
3 weeks, and 11.1 (5.4) min during the last 3 weeks.
Patients were able to maintain the very high inten-
sity during the training sessions without getting
asthma symptoms that could not be relieved with
1–2 puffs of SABA or a short pause (1–2 min) from
training. No muscle injuries were reported beside
transient muscle soreness.
Changes in VO2 max, PPO and body weight
After the intervention period, mean VO2 max had
improved from 38.4 (8.9) to 41.5 (9.5) ml/min/kg,
(p < 0.0001), and PPO from 241 (51) to 270 (61) W,
(p < 0.0001). A nonsignificant reduction in total
body weight at 1.0 (2.2) kg was observed (Table 2).
Table 1. Baseline characteristics. Results are no.(%) or mean
(SD) unless otherwise specified.
Patients (completed study) 29
Men (n (%)) 16 (55)
Age (years) 39.4 (12.5)
BMI (kg/m2) 24.9 (2.5)
Years with asthma (years) 17 (14)
Use ICS (n (%)) 22 (76)
ICS dose
(Budesonide equivalents at entry, ug)
645 (440)
Smoking (n (%))
No 21 (72)
Yes 0 (0)
Former 8 (29)
ACQ 1.7 (0.6)
ACQ < 1.5 (n (%)) 18 (62)
FEV1%pred 84 (13)
FVC %pred 93 (10)
FEV1/FVC 0.91 (0.08)
Positive AHR (n (%))
(n = 28)
21 (75)
FeNO (ppb) a 28.5 (23.8)
Atopy (n (%)) 21 (72)
ACQ = Asthma Control Questionnaire Score
ICS = Inhaled corticosteroids
FEV1%pred. = Forced expiratory volume in 1 s in percent of predicted
FVC %pred. = Forced vital capacity in percent of predicted
AHR = airway hyperresponsiveness
FeNO = Fraction of exhaled nitric oxide (parts per billion).
a Median (interquartile range).
Figure 1. Mean time spent in each heart rate zone during one
training session at week 1–2, 3–5 and 6–8.
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Association between pre-intervention ACQ and
changes in VO2 max and PPO
The associations between pre-intervention ACQ
scores and training response assessed as improve-
ments in VO2 max and PPO were statistically non-
significant (Table 3). Adjusting for sex and pre-
intervention VO2 max and PPO did not change
these findings. Those patients (n = 18) who had an
ACQ ≥1.5 improved in VO2 max from 38.2 (7.7) to
41.7 (6.9) (ml/min/kg) which was not significantly
different from the improvements obtained in the 11
patients with ACQ < 1.5, who improved ACQ from
38.5 (9.7) to 41.4 (11.0) (ml/min/kg), (p = 0.54)
(Figure 2).
Pre-intervention FEV1%pred and changes in
VO2 max and PPO
The associations between pre-intervention FEV1%pred.
and improvements in VO2 max and PPO were statisti-
cally nonsignificant (Table 3). Adjusting for sex and
pre-intervention VO2 max and PPO did not change
any of the findings.
Pre-intervention FeNO and changes in VO2 max
and PPO
The associations between pre-intervention levels of
FeNO and improvements in VO2 max and PPO were
statistically nonsignificant, and the findings remained
after adjusting for sex and pre-intervention VO2 max
and PPO (Table 3).
Pre-intervention AHR and changes in VO2 max
and PPO
The associations between pre-intervention mannitol
RDR and improvements in VO2 max and PPO were
statistically nonsignificant, and this remained after
adjustment for sex and pre-intervention VO2 max
Table 2. Body composition, VO2 max and peak power output
pre-intervention and changes from pre-to post-intervention.
Results are mean (SD).
Patients (n = 29)
Pre-
intervention
Change from
pre- to post-
intervention
(p-
value)
Weight (kg) 76.4 (9.8) −1.0 (2.2) 0.15
VO2 max (ml/min) 2921 (776) 201 (249) <0.0001
VO2 max (ml/min/kg) 38.4 (8.9) 3.1 (3.6) <0.0001
PPO (watt) 241 (51) 28.3 (51) <0.0001
VO2 max = maximal oxygen consumption.
PPO = peak power output.
Table 3. Associations between clinical outcomes (pre-intervention) and improvements in VO2 max and peak power output
following the exercise intervention.
Improvement in VO2 max (ml/min/kg) Improvement in peak power output (watt)
Clinical outcomes (pre-intervention) β S.E P
β
adjustedb S.E. P β S.E P
β
adjustedc S.E. P
ACQ −0.84 1.18 0.49 −0.85 1.2 0.50 3.7 7.8 0.64 4.3 8.2 0.61
FEV1%pred. 0.01 0.06 0.82 0.02 0.06 0.81 0.46 0.36 0.22 0.41 0.37 0.28
AHR a
(n = 28)
0.84 1.5 0.58 0.88 5.4 0.59 4.2 9.8 0.67 5.5 10.1 0.60
FeNO (ppb) −0.01 0.04 0.80 −0.01 0.04 0.82 0.24 0.26 0.37 0.30 0.29 0.30
FEV1%pred. = Forced expiratory volume in one second in percent of predicted.
AHR = Airway hyperresponsiveness.
FeNO (ppb) = Fractional exhaled nitric oxide (parts per billion).
a Log response-dose slopes.
b Adjusted for baseline VO2 max (ml/min/kg) and sex.
c Adjusted for baseline peak power output and sex.
Figure 2. VO2 max pre- and post-intervention in patients with
partly and well-controlled asthma (Asthma Control Questionnaire
(ACQ) score <1.5) and uncontrolled asthma (ACQ≥1.5). § Pre-
intervention VO2 max between patients with ACQ < and ≥ 1.5.
‡ Change in VO2 max between patients with ACQ < and ≥ 1.5.
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and PPO (Table 3). Those patients (n = 21) who had a
positive mannitol test improved in VO2 max from 38.0
(8.4) to 41.4 (8.3) (ml/min/kg) which was not signifi-
cantly different from the improvements obtained in the
7 patients with a negative mannitol test, who improved
in VO2 max from 40.1 (8.3) to 43.0 (13.4) (ml/min/kg),
(p = 0.45) (Figure 3).
Discussion
The present study demonstrates in a group of
untrained asthma patients that levels of asthma control,
FEV1, FeNO and AHR do not affect patients’ ability to
engage in high-intensity training and obtain a signifi-
cant training response after 8 weeks of training.
To our knowledge, this is the first study to assess
this question. Only one previous study has tested high-
intensity training in untrained asthma patients [18]. In
this noncontrolled trial, 32 asthma patients underwent
a 10-week rehabilitation program consisting of high-
intensity interval training in an indoor heated swim-
ming pool or in a gymnasium. The program included
training 5 days/week during the first 2 weeks followed
by 8 weeks of training three times/w plus an education
program (physiology, medication, inhalation and
breathing techniques). The training both on land and
in water was found to be safe and improved exercise
capacity and asthma symptoms. However, when com-
pared to the training program in the EFFORT Asthma
study, the program was rather comprehensive and it
might not be feasible in every clinical setting to train in
indoor pools. With the indoor spinning program we
have proven the feasibility of a real-life training setup
that could easily be applied inside a rehabilitation cen-
tre or in hospital training facility. The structure and
progression of training through the 8-week training
period was simple, and it allowed on-going enrolment
of patients’ to the program, which can be an advantage
in a real-life setting. Furthermore, the use of heart-rate
monitors enabled the instructors to ensure patients’
adherence to the high-intensity protocol during
training.
We observed a mean improvement in VO2 max of
~8%, which is comparable to the findings of other
studies of exercise interventions in asthma. In the
study by França-Pinto et al [19], patients exercised
for 30 min two times/w for 3 months on a treadmill
at intensities between 60 and 80% of HRmax. The
average improvement in VO2 max was ~3.5%. Dogra
et al [20] performed a non-randomized study including
12 weeks of supervised aerobic training twice weekly
plus resistance training once a week, which led to an
increase in VO2 max of ~9.5%. This indicates that
though our high-intensity training program lasted just
8 weeks, it effectively improved VO2 max when com-
pared to previous studies. Furthermore, when looking
at findings from exercise intervention studies in
healthy sedentary volunteers, the observed magnitude
of VO2 max improvements among our included
asthma patients were at a comparable level [21].
It could be anticipated that patients who experience
exercise-induced asthma would be less capable of com-
pleting high-intensity training. As exercised-induced
asthma is associated with AHR to mannitol, a provoca-
tion test with mannitol can be regarded as a surrogate
marker of exercise-induced asthma [22]. We here
report that having AHR to mannitol did not affect
asthma patients’ ability to comply to high-intensity
interval training and thus suggests that exercise-
induced asthma should not be considered a contra-
indication for engaging in high-intensity interval
training.
There are limitations to our study. First of all, it is not
known if the included patients are a representative sample
of asthma patients in the general population, and thus the
magnitude of external validity of our findings. Themajority
of patients were enrolled after they had responded to a
newspaper advertisement, and it is likely that this intro-
duced a certain degree of selection bias. Furthermore,
though included patients ranged in degree of AHR to
mannitol from mild to severe and all had ACQ scores
≥1.0 indicating partly or uncontrolled asthma, patients
who were on oral corticosteroids or biological treatment
were not included and no patients received ICS in doses
Figure 3. VO2 max pre- and post-intervention in patient with
and without pre-intervention airway hyperresponsiveness
(AHR). § Pre-intervention values of VO2 max between patients
with a positive and a negative mannitol test.
‡ Change from pre- to post-intervention in VO2 max between
patients with and without pre-intervention AHR.
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≥1600 ug budesonide equivalents per day plus a second
controller (indicating severe asthma). Our findings may
therefore be most applicable to patients with mild to mod-
erate asthma and should not be assumed to apply also in
more severe disease.
In conclusion, we demonstrate here that high-intensity
interval training on indoor bikes effectively improves VO2
max and PPO in untrained asthma patients regardless of
their levels of asthma control, FEV1, FeNO and AHR.
These findings suggest that clinicians should encourage
asthma patients to engage in high-intensity interval
training.
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